Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis.
Kitade M, Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Sawai M, Yoshida M, Morioka C, Tsujimoto T, Kawaratani H, Fukui H. Kitade M, et al. Among authors: yamao j. World J Gastroenterol. 2009 Nov 7;15(41):5193-9. doi: 10.3748/wjg.15.5193. World J Gastroenterol. 2009. PMID: 19891019 Free PMC article.
Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Douhara A, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Morioka C, Fujimoto M, Uemura M, Fukui H. Yoshiji H, et al. Among authors: yamao j. Mol Med Rep. 2012 Feb;5(2):539-44. doi: 10.3892/mmr.2011.676. Epub 2011 Nov 15. Mol Med Rep. 2012. PMID: 22089860 Clinical Trial.
Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis.
Namisaki T, Moriya K, Noguchi R, Kitade M, Kawaratani H, Yamao J, Mitoro A, Yoshida M, Sawai M, Uejima M, Mashitani T, Takeda K, Okura Y, Kaji K, Takaya H, Aihara Y, Douhara A, Nishimura N, Sawada Y, Sato S, Seki K, Yoshiji H. Namisaki T, et al. Among authors: yamao j. Hepatol Res. 2017 Mar;47(3):E178-E186. doi: 10.1111/hepr.12746. Epub 2016 Jul 21. Hepatol Res. 2017. PMID: 27189879 No abstract available.
Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.
Kawaratani H, Fukui H, Moriya K, Noguchi R, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Nishimura N, Takaya H, Aihara Y, Sawada Y, Sato S, Seki K, Mitoro A, Yamao J, Yoshiji H. Kawaratani H, et al. Among authors: yamao j. Hepatol Res. 2017 Aug;47(9):854-861. doi: 10.1111/hepr.12826. Epub 2016 Nov 9. Hepatol Res. 2017. PMID: 27704665
DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis.
Asada K, Aihara Y, Takaya H, Noguchi R, Namisaki T, Moriya K, Uejima M, Kitade M, Mashitani T, Takeda K, Kawaratani H, Okura Y, Kaji K, Douhara A, Sawada Y, Nishimura N, Seki K, Mitoro A, Yamao J, Yoshiji H. Asada K, et al. Among authors: yamao j. World J Hepatol. 2016 Oct 8;8(28):1194-1199. doi: 10.4254/wjh.v8.i28.1194. World J Hepatol. 2016. PMID: 27729955 Free PMC article.
Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients.
Namisaki T, Moriya K, Kitade M, Kawaratani H, Takeda K, Okura Y, Takaya H, Nishimura N, Seki K, Kaji K, Sato S, Sawada Y, Yamao J, Mitoro A, Uejima M, Mashitani T, Shimozato N, Nakanishi K, Furukawa M, Saikawa S, Kubo T, Yoshiji H. Namisaki T, et al. Among authors: yamao j. Eur J Gastroenterol Hepatol. 2017 Jan;29(1):23-30. doi: 10.1097/MEG.0000000000000765. Eur J Gastroenterol Hepatol. 2017. PMID: 27755231
A Patient with Hepatocellular Carcinoma with Isolated Right Atrial Metastases.
Takaya H, Kawaratani H, Seki K, Okura Y, Kitade M, Namisaki T, Sawai M, Sawada Y, Kubo T, Mitoro A, Yamao J, Yoshiji H. Takaya H, et al. Among authors: yamao j. Intern Med. 2017 Oct 1;56(19):2589-2594. doi: 10.2169/internalmedicine.8568-16. Epub 2017 Sep 6. Intern Med. 2017. PMID: 28883235 Free PMC article.
Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.
Douhara A, Namisaki T, Moriya K, Kitade M, Kaji K, Kawaratani H, Takeda K, Okura Y, Takaya H, Noguchi R, Nishimura N, Seki K, Sato S, Sawada Y, Yamao J, Mitoro A, Uejima M, Mashitani T, Shimozato N, Saikawa S, Nakanishi K, Furukawa M, Kubo T, Yoshiji H. Douhara A, et al. Among authors: yamao j. Oncol Lett. 2017 Sep;14(3):3028-3034. doi: 10.3892/ol.2017.6489. Epub 2017 Jun 28. Oncol Lett. 2017. PMID: 28927051 Free PMC article.
88 results